Surrozen Inc SRZN

US Biotechnology

$31.98 ▲ +7.89% (+$2.34)

🔥 High Short Interest 🎈 Low Float

Open $29.83

Prev Close $29.64

Day Range $29.50 – $32.55

52W Range $11.39 – $37.83

Market Cap $375.88M

Beta 0.51

EPS (TTM) $-35.79

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-11-23
Shares Out.	11,610,000
Website	surrozen.com ↗
Phone	13026587581
Employees	44
Revenue	$5.0M
Gross Profit	$5.0M
Net Income	$50.2M
Free Cash Flow	-$35.0M
Total Assets	$115.6M
Total Liabilities	$334.3M
Equity	-$218.7M

About Surrozen Inc

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Surrozen Inc is a publicly traded company under the ticker symbol SRZN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.